Reported Adverse Effects In the available case series and observational literature, the most commonly reported adverse effects include: Injection-site redness or mild induration in approximately 8 to 12% of users Transient nausea, most often associated with oral formulations or higher injectable doses Lightheadedness in a small number of patients shortly after injection (under 2% of reported cases) Vivid dreams or mild sleep changes, reported anecdotally by a subset of users with no clear mechanistic explanation No published human case reports as of July 2025 document serious organ toxicity, malignancy, or endocrine disruption attributable to BPC-157
It is now even more important that treatments for type 2 diabetes should be selected not just solely on their glucose lowering capability but also on their overall ability to lower mortality
Clinical-grade sourcing with verified COA is the appropriate standard for human use
4 min read Who Qualifies for GLP-1
Presented for research literature review only Yurdakk M et al
Michigan, United States Great prices, great product, felt a difference in just a few days, love genx Smooth checkout and fast shipping